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R(O-Peracylated a-D-gluco- and -galacto-hept-2-ulopyranosylbromide)onamides gave the corresponding(alkyl b-D-glyco-hept-2-ulopyranoside)onamides under Koenigs–Knorr conditions, and similar aryl glyco-
sides were obtained with sodium phenolates; (aryl and hetaryl 2-thio-b-D-gluco-hept-2-ulopyrano-
side)onamides were formed with thiophenols in the presence of K2CO3 in acetone, and reactions with
aniline in CH2Cl2 furnished (N-phenyl b-D-glyco-hept-2-ulopyranosylamine)onamides. Some deprotected
derivatives of D-gluco conﬁguration obtained by the Zemplén protocol showed no signiﬁcant inhibition
against rabbit muscle glycogen phosphorylase b.
 2009 Published by Elsevier Ltd.E
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CC-(2,3,4,6-Tetra-O-acyl-1-bromo-1-deoxy-b-D-glycopyranosyl)for-mamides (3,4,5,7-tetra-O-acyl-a-D-glyco-hept-2-ulopyranosylbr-omide)onamides)1–5 (e.g., 11,2 and 25) proved versatile starting
materials for the syntheses of diverse monosaccharide derivatives.
Thus, their reactions with nucleophiles such as H2O,6 azide ion,7,8
nitriles,9 acetone and DMSO,10 cyanate and thiocyanate ions,2,3,6
the latter two resulting in cyclisations to give glycopyranosylid-
ene-spiro-(thio)hydantoins efﬁcient glucose analogue glycogen
phosphorylase inhibitors (GPIs),11–15 as well as eliminations to
substituted glycals1 were reported. Several derivatives of D-glucose
with a CONH2 moiety in the a-anomeric position were shown to be
GPIs,16–18 although a clearcut conclusion for the role of this group
could not yet be drawn.8 In order to produce new compounds of
this type, and to study the reactivity of hept-2-ulopyranosylona-
mide bromides towards further nucleophiles, we have investigated
the preparation of some O-, S- and N-glycosidic derivatives from 1
and 2.
Treatment of 1 with MeOH or EtOH as the solvent in the pres-
ence of Ag2CO319 gave methyl and ethyl glycosides 3 and 4, respec-
tively (Table 1, entries 1 and 2). Decreasing the amount of EtOH in
CH2Cl2 as co-solvent was investigated (entries 3–6) to show that as
few as 2 equiv of the alcohol gave satisfactory results. Changing the
promoter to the more efﬁcient AgOTf signiﬁcantly reduced the
reaction time and increased the yield (entry 6). A large excess of
n-BuOH gave the corresponding glycoside 7 in satisfactory yield
(entry 7). On the other hand, reactions of 1 with t-BuOH or BnOH
(entries 8 and 9), and similarly, those of 2 with EtOH or n-BuOHElsevier Ltd.
8; fax: +36 52 453 836.
ák).
. et al., Carbohydr. Res. (200(entries 12 and 13) gave signiﬁcant amounts of the corresponding
O-peracylated a-D-glyco-hept-2-ulopyranosonamides 152 and 164,5
besides the expected glycosides 7 and 8 as well as 12 and 14,
respectively. The reaction of 2-nitrophenol with 1 in the presence
of AgOTf and Et3N or DBU gave 9 in 32% and 24% yields, respec-
tively. Under phase transfer conditions (2-nitrophenol in CH2Cl2,
1 M NaOH in water, Bu4NBr) 9 could not be observed in the reac-
tion mixture. Therefore, we turned to the sodium salt of 2-nitro-
phenol (entry 10), however, this reaction again gave 9 in a low
yield accompanied by 15. On the contrary, sodium 4-nitropheno-
late (entry 11) gave the expected 10 in good yield. The steric acces-
sibility of the nucleophilic part of the reagents may be responsible
for the large differences in the outcomes of these reactions. Depro-
tection of glycosides 4 and 12 was effected by the Zemplén proto-
col, while 10 was deacetylated by KCN/MeOH to give 5, 13 and 11,
respectively.
For the formation of N-phenyl-glycosylamines,20,21 1 and 2
were reacted with aniline to give 17 and 18, respectively (Scheme
1). The latter was deprotected by the Zemplén method to yield 19.
To obtain S-glycosides,22 2was reacted with thiols in acetone in
the presence of K2CO3 to give the expected products 20, 22 and 24
in good yields (Scheme 1). For deprotection of these compounds
the Zemplén method was applied to give 21, 23 and 25, respec-
tively, without difﬁculties.
Structure elucidation of the new compounds was straightfor-
ward by NMRmethods. The 4C1 conformation of the pyranose rings
followed from the vicinal proton–proton coupling constants.
For most representative compounds, the conﬁguration of the ano-
meric carbon was established on the basis of three-bond heteronu-
clear couplings between H-2 (parent sugar numbering) and the9), doi:10.1016/j.carres.2009.02.011
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Table 1
Preparation of (alkyl or aryl b-D-glyco-hept-2-ulopyranoside)onamides
O
RR1
R
R
OR'
CONH2
O
R
R2
R
R
CONH2
Br
R'OH or 
R'ONa O
R
R2
R
R
CONH2+promoter,
solvent, OH
R1
R2
R1
1 R = R1 = OAc, R2 = H
2 R = R2 = OBz, R1 = H 12, 14       R = R2 = OBz, R1 = H
3, 4, 6-10  R = R1 = OAc, R2 = H
4             5  R = R1 = OH, R2 = H, R' = Et (98%)
10            11 R = R1 = OH, R2 = H, R' = 4-NO2-C6H4 (99%)
12            13 R = R2 = OH, R1 = H, R' = Et (98%)
i    NaOMe, MeOH, rt
ii   KCN, MeOH, rt
i
ii
i
rt
15 R = R1 = OAc, R2 = H
16 R = R2 = OBz, R1 = H
Entry Starting compound R0OH or R0ONa (equiv) Promoter Solvent Reaction time Product(s) (Yield [%])
1 1 MeOH (as solvent) Ag2CO3 MeOH 2 h 3 (89) —
2 1 EtOH (as solvent) Ag2CO3 EtOH 2 h 4 (85) —
3 1 EtOH (70) Ag2CO3 CH2Cl2 2 h 4 (84) —
4 1 EtOH (10) Ag2CO3 CH2Cl2 1 d 4 (93) —
5 1 EtOH (2) Ag2CO3 CH2Cl2 2 d 4 (50) —
6 1 EtOH (2) AgOTf CH2Cl2 5 min 4 (80) —
7 1 n-BuOH (70) Ag2CO3 CH2Cl2 2 d 6 (90) —
8 1 t-BuOH (10) Ag2CO3 CH2Cl2 7 d 7 (21) 15 (29)
9 1 C6H5CH2OH (10) Ag2CO3 CH2Cl2 7 d 8 (31) 15 (9)
10 1
ONa
NO2(5)
— CH2Cl2 36 d 9 (24) 15 (25)
11 1
ONa
O2N (5)
— CH3CN 1 d 10 (82) —
12 2 EtOH (50) Ag2CO3 CH2Cl2 2 d 12 (87) 16 (10)
13 2 n-BuOH (43) Ag2CO3 CH2Cl2 6 d 14 (56) 16 (31)
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Eexocyclic carbonyl of the amide group measured as earlier.8 Thevalues larger than 4 Hz suggested trans arrangement of the rele-
vant atoms in the 4C1 conformation.8 In case of 4, a single crystal
X-ray structure determination unequivocally conﬁrmed the ano-
meric conﬁguration (Fig. 1).
The investigated substitution reactions were clean, that is, dis-
regarding by-products 15 and 16 no other compounds than the iso-
lated products were observed by TLC. This reveals exclusiveU
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R
R2
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R
NHPh
CONH2
O
R
R2
R
R
CONH2
Br
PhNH2, CH2Cl2, rt
1 R = R1 = OAc, R2 = H
2 R = R2 = OBz, R1 = H
17 R = R1 = OAc, R2 = H (75%)
18 R = R2 = OBz, R1 = H (55%) 19 R = R2 = 
R'SH, K2CO3, ace
from 2
i
R1
R1
Scheme
Please cite this article in press as: Nagy, V. et al., Carbohydr. Res. (200stereoselectivity for each transformation. An explanation for this
can be an SN2 type replacement of bromine in the cases of pheno-
lates, aniline and thiolates. In the reactions with alcohols promoted
by silver salts neighbouring group participation of the 2-acyloxy
substituent in the possible intermediate glycosylium ion may ac-
count for the inversion. However, given the electron-withdrawing
character of the carboxamido group, formation of the glycosylium
ion may be unfavourable. Therefore, an electrophilically assistedOH, R1 = H (54%) i   NaOMe, MeOH, rt
tone, rt O
OR
RO
RO
RO
SR'
CONH2
N
S
N
20 (79%)               21 (86%)
22 (73%)               23 (62%)
24 (76%)               25 (47%)
i
i
i
R'                              R = Bz                   R = H
1.
9), doi:10.1016/j.carres.2009.02.011
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Figure 1. Ortep view at 40% probability level and partial crystallographic number-
ing scheme of compound 4. Selected torsion angles () for the two molecules in the
asymmetric unit: O5–C1–O1–C8: 58 and 46; O1–C1–C7–N1: 3 and 12.
V. Nagy et al. / Carbohydrate Research xxx (2009) xxx–xxx 3
CAR 4933 No. of Pages 7, Model 5G
20 February 2009 Disk Used
ARTICLE IN PRESSsubstitution of bimolecular character can also be taken into
consideration.
The deprotected compounds were assayed against rabbit mus-
cle glycogen phosphorylase b as described earlier,3,6 and showed
no signiﬁcant inhibition (13 21% at 625 lM; 19 IC50 > 60 mM; 21,
23, 25 no inhibition at 625 lM).T
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1. Experimental
1.1. General methods
Melting points were measured in open capillary tubes or on a
Koﬂer hot-stage and are uncorrected. Optical rotations were deter-
mined with a Perkin–Elmer 241 polarimeter at rt. NMR spectra
were recorded with Bruker 200 (200/50 MHz for 1H/13C), Bruker
360 (360/90 MHz for 1H/13C) or Avance DRX 500 (500/125 MHz
for 1H/13C) spectrometers. Chemical shifts are referenced to Me4Si
(1H) or to the residual solvent signals (13C). TLC was performed on
DC-Alurolle Kieselgel 60 F254 (Merck), and the plates were visual-
ised under UV light and by gentle heating. For column chromatog-
raphy, Kieselgel 60 (Merck, particle size 0.063–0.200 mm) was
used. Dichloromethane was distilled from P4 10 and acetone from
CaSO4) and stored over 4 Å molecular sieves. Organic solutions
were dried over anhydrous MgSO4 and were concentrated under
diminished pressure at 40–50 C (water bath).
1.2. General procedure I for the preparationofC-(2,3,4,6-tetra-O-
acetyl-1-alkoxy-a-D-glycopyranosyl)formamides ((alkyl 3,4,5,7-
tetra-O-acetyl-b-D-galacto-hept-2-ulopyranoside)onamides)
To a solution of a C-(2,3,4,6-tetra-O-acyl-1-bromo-1-deoxy-b-D-
glycopyranosyl)formamide, ((3,4,5,7-tetra-O-acyl-a-D-glyco-hept-
2-ulopyranosylbromide)onamide) (11,2 or 2,5 0.3 mmol) in dry
CH2Cl2 (2 mL) containing molecular sieves (0.1 g, 3 Å) an alcohol
(Table 1) and Ag2CO3 (1 equiv, 0.30 mmol, 0.08 g) or silver triﬂate
(1 equiv, 0.30 mmol, 0.07 g) and Et3N (1 equiv, 0.30 mmol, 39 lL)
were added. The reaction mixture was stirred in the dark at rt until
TLC (1:1 EtOAc–hexane) showed the complete transformation of
the starting material. The mixture was then ﬁltered on a Celite
pad, and the solvent was removed under diminished pressure.Please cite this article in press as: Nagy, V. et al., Carbohydr. Res. (200E
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The crude product was crystallised from EtOAc–hexane or puriﬁed
by column chromatography.
1.3. General procedure II for thepreparationofC-(2,3,4,6-tetra-O
-acyl-1-deoxy-1-phenylamino-a-D-glycopyranosyl)formamides
((N-Phenyl 3,4,5,7-tetra-O-acyl-b-D-glyco-hept-2-ulopyranosyl-
amine)onamides)
To a solution of C-(2,3,4,6-tetra-O-acyl-1-bromo-1-deoxy-b-D-
glycopyranosyl)formamide, ((3,4,5,7-tetra-O-acyl-a-D-glyco-hept-
2-ulopyranosylbromide)onamide) (11,2 or 2,5 0.3 mmol) in dry
CH2Cl2 (2 mL) containing molecular sieves (0.1 g, 3 Å), aniline
(50 equiv to 1 and 5 equiv to 2) was added. The reaction mixture
was stirred at rt until TLC (1:1 EtOAc–hexane) showed the com-
plete transformation of the starting sugar (1–2 d). The mixture
was then ﬁltered on a Celite pad and the solvent was evaporated.
The residue was dissolved in EtOAc, the solution was washed with
water, diluted hydrochloric acid, and satd aq NaHCO3 solution.
After drying and solvent removal the crude product was crystal-
lised from EtOAc–hexane or puriﬁed by column chromatography.
1.4. General procedure III for the preparation of C-(2,3,4,6-
tetra-O-benzoyl-1-deoxy-1-aryl or heteroarylsulfanyl-a-D-
glucopyranosyl)formamides ((aryl- or heteroaryl- 3,4,5,7-tetra-
O-benzoyl-2-thio-b-D-gluco-hept-2-ulopyranoside)onamides)
To a solution of C-(1-bromo-1-deoxy-2,3,4,6-tetra-O-benzoyl-b-
D-glucopyranosyl)-formamide,5 ((3,4,5,7-tetra-O-benzoyl-a-D-glu-
co-hept-2-ulopyranosylbromide)onamide) (2, 0.20 g, 0.28 mmol)
in dry acetone (3 mL) containing molecular sieves (0.1 g, 3 Å), a
thiol (1.40 mmol) and K2CO3 (0.20 g, 1.40 mmol) were added. The
reaction was stirred at rt until TLC (1:2 EtOAc–hexane) showed
complete transformation of the starting material. The mixture
was then ﬁltered, diluted with CH2Cl2 (5 mL), washed with satd
aq NaHCO3 solution (2  5 mL), and water (1  5 mL). After drying
and solvent removal, the crude product was puriﬁed by column
chromatography.
1.5. General procedure IV for the Zemplén-deacylation
To a solution of an O-acyl protected compound in dry MeOH
1–2 drops of a 1 M methanolic NaOMe solution were added,
and the reaction mixture was maintained at rt until completion
of the transformation TLC (1:1 CHCl3–MeOH). Amberlyst 15
(H+ form) was then added to remove sodium ions, the resin was ﬁl-
tered off, and the solvent was removed under diminished pressure.
If the residue was chromatographically not uniform it was puriﬁed
by column chromatography or crystallisation.
1.6. C-(2,3,4,6-Tetra-O-acetyl-1-methoxy-a-D-galactopyranosyl)
formamide ((Methyl 3,4,5,7-tetra-O-acetyl-b-D-galacto-hept-2-
ulopyranoside)onamide) (3)
This compound was prepared from 1 (0.30 g 0.66 mmol)
according to General procedure I. The crude product was crystal-
lised to give 3 (0.22 g, 85%) as a yellowish crystalline product.
Mp: 120–122 C; [a]D +69 (c 1.03, CHCl3); 1H NMR (CDCl3,
360 MHz): d (ppm) 6.65 (s,1H, NH), 5.93 (s, 1H, NH), 5.86 (dd,
1H, J2,3 10.5 Hz, J3,4 3.1 Hz, H-3), 5.53 (d, 1H, J2,3 10.5 Hz, H-2),
5.50 (dd, 1H, J3,4 3.1 Hz, J4,5 1.5 Hz, H-4), 4.85 (ddd, 1H, J5,6
6.3 Hz, J5,605.3 Hz, H-5), 4.12 (dd, 1H, J6,60 11.0 Hz, H-6), 4.05 (dd,
1H, J6,60 11.0 Hz, H-60), 3.48 (s, 3H, CH3), 2.14, 2.04, 2.01, 1.95
(4  s, 12H, OCOCH3); 13C NMR (CDCl3, 90 MHz): d (ppm): 170.4
(CONH2, 3JH-2,CO = 4.7 Hz), 169.7 (2), 169.6 (2) (CO), 97.5 (C-1),
71.1, 70.0, 67.4, 64.7 (C-2 to C-5), 61.5 (C-6), 49.8 (OCH3), 20.7,9), doi:10.1016/j.carres.2009.02.011
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20.6, 20.5 (COCH3). Anal. Calcd for C16H23NO11 (405.36): C, 47.41;
H, 5.72; N, 3.46. Found: C, 47.00; H, 5.52; N, 3.23.
1.7. C-(2,3,4,6-Tetra-O-acetyl-1-ethoxy-a-D-galactopyranosyl)
formamide ((ethyl 3,4,5,7-tetra-O-acetyl-b-D-galacto-hept-2-
ulopyranoside)onamide) (4)
This compound was prepared from 1 (0.20 g 0.44 mmol)
according to General procedure I. The crude product was crystal-
lised from hexane to give 4 (0.16 g, 85%) as a white crystalline
product. Mp 135–137 C; [a]D +57 (c 1.04, CHCl3); 1H NMR (CDCl3,
360 MHz): d (ppm) 6.69 (s, 1H, NH), 6.26 (s, 1H, NH), 5.85 (dd, 1H,
J2,3 10.3 Hz, J3,4 3.6 Hz, H-3), 5.51 (d, 1H, J2,3 10.3 Hz, H-2), 5.46 (dd,
1H, J3,4 3.6 Hz, J4,5 1.2 Hz, H-4), 4.81 (pseudo t, 1H, J5,6 6.8 Hz, J5,60
6.7 Hz, H-5), 4.10–3.99 (m, 2H, H-6, H-60), 3.88–3.70 (m, 2H,
CH2), 2.12, 2.05, 1.99, 1.91 (4  s, 12H, OCOCH3), 1.19 (m, 3H,
CH3), 13C NMR (CDCl3, 90 MHz): d (ppm) 170.3 (CONH2 3JH-
2,CO = 6.1 Hz), 169.9 (2), 169.7 (2) (CO), 97.4 (C-1), 70.9, 70.0,
67.4, 65.4 (C-2 to C-5), 61.4 (C-6). 58.3 (CH2), 20.7, 20.6, 20.5 (2)
(COCH3), 15.3 (CH3). Anal. Calcd for C17H25NO11 (419.10): C,
48.69; H, 6.01; N, 3.34. Found: C, 48.54; H, 6.04; N, 3.49.
1.8. C-(1-Ethoxy-a-D-galactopyranosyl)formamide ((ethyl b-D-
galacto-hept-2-ulopyranoside)onamide) (5)
This compound was prepared from 4 (0.20 g 0.47 mmol)
according to General procedure IV to give 5 (0.12 g, 98%) as a yel-
lowish oil. Rf = 0.32 (7:3 CHCl3–MeOH); [a]D +61 (c 1.26, H2O); 1H
NMR (D2O, 360 MHz): d (ppm) 4.28–3.55 (m, 8H, H-2, H-3, H-4, H-
5, H-6, H-60, CH2), 1.18 (t, 3H, J 7.3 Hz, CH3), 13C NMR (D2O,
90 MHz): d (ppm) 173.7 (CONH2, 3JH-2,CO = 4.8 Hz), 100.6 (C-1),
76.4, 72.8, 71.0, 70.1 (C-2 to C-5), 62.7 (C-6), 59.4 (CH2), 15.9
(CH3). Anal. Calcd for C9H17NO7 (251.24): C, 43.03; H, 6.82; N,
5.58. Found: C, 43.54; H, 6.63; N, 5.12.
1.9. C-(2,3,4,6-Tetra-O-acetyl-1-n-buthoxy-a-D-galactopyran-
osyl)formamide ((n-buthyl 3,4,5,7-tetra-O-acetyl-b-D-galacto-
hept-2-ulopyranoside)onamide) (6)
This compound was prepared from 1 (0.20 g 0.44 mmol)
according to General procedure I. The crude product was crystal-
lised from hexane to give 6 (0.18 g, 90%) as a white crystalline
product. Mp: 97–99 C; [a]D +48 (c 1.24, CHCl3); 1H NMR (CDCl3,
360 MHz): d (ppm) 6.65 (s, 1H, NH), 6.42 (s, 1H, NH), 5.84 (dd,
1H, J2,3 10.5 Hz, J3,4 3.1 Hz, H-3), 5.50 (d, 1H, J2,3 10.5 Hz, H-2),
5.47 (dd, 1H, J3,4 3.1 Hz, J4,5 1.2 Hz, H-4), 4.81 (pseudo t, 1H, J5,6
5.8 Hz, J5,60.8 Hz, H-5), 4.15–3.99 (m, 2H, H-6, H-60), 3.80–3.64 (m,
2H, CH2), 2.11, 2.01, 1.98, 1.91 (4  s, 12H, OCOCH3), 1.60–1.55
(m, 2H, CH2), 1.38–1.32 (m, 2H, CH2), 0.91 (t, 3H, J 6.8 Hz, CH3);
13C NMR (CDCl3, 90 MHz): d (ppm) 170.3, 169.9, 169.7, 169.6
(CO), 170.0 (CONH2, 3JH-2,CO = 6.1 Hz), 97.3 (C-1), 70.9, 70.0,
67.3, 65.4 (C-2 to C-5), 62.1 (C-6), 61.3, 31.5 (CH2), 20.6, 20.5,
20.5 (COCH3) 19.0 (CH2), 13.6 (CH3). Anal. Calcd for C19H29NO11
(447.44): C, 51.00; H, 6.53; N, 3.13. Found: C, 51.15; H, 6.57; N,
3.29.
1.10. C-(2,3,4,6-Tetra-O-acetyl-1-t-buthoxy-a-D-galactopyr-
anosyl)formamide ((t-buthyl 3,4,5,7-tetra-O-acetyl-b-D-galacto-
hept-2-ulopyranoside)onamide) (7)
This compound was prepared from 1 (0.20 g 0.44 mmol)
according to General procedure I, and was puriﬁed by column
chromatography (1:1 EtOAc–hexane) to give 7 (0.04 g, 21%) as a
colourless oil, and in the second fraction it gave compound 15
(29%). Rf = 0.42 (3:1 EtOAc–hexane); [a]D +19 (c 1.02, CHCl3); 1H
NMR (CDCl3, 360 MHz): d (ppm) 6.81 (s, 1H, NH), 6.19 (s, 1H,Please cite this article in press as: Nagy, V. et al., Carbohydr. Res. (200E
D
P
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NH), 5.84 (dd, 1H, J2,3 10.5 Hz, J3,4 3.1 Hz, H-3), 5.60 (d, 1H, J2,3
10.5 Hz, H-2), 5.50 (dd, 1H, J3,4 3.1 Hz, J4,5 1.5 Hz, H-4), 4.91 (pseu-
do t, 1H, J5,6 6.3 Hz, J5,60 6.3 Hz, H-5), 4.13–4.10 (m, 2H, H-6, H-60),
2.10, 2.02, 2.00, 1.93 (4  s, 12H, OCOCH3), 1.42 (s, 9H, C(CH3)3);
13C NMR (CDCl3, 90 MHz): d (ppm) 171.4 (CONH2,
3JH-2,CO = 5.8 Hz), 170.3, 169.8, 169.7 (2) (CO), 98.7 (C(CH3)3),
80.1 (C-1), 71.3, 70.0, 96.9, 67.5 (C-2 to C-5), 61.4 (C-6), 30.1
(C(CH3)3), 20.8, 20.6 (3) (COCH3). Anal. Calcd for C19H29NO11
(447.44): C, 51.00; H, 6.53; N, 3.13. Found: C, 51.17; H, 6.52; N,
3.30.
1.11. C-(2,3,4,6-Tetra-O-acetyl-1-benzyloxy-a-D-galactopyran-
osyl)formamide ((benzyl 3,4,5,7-tetra-O-acetyl-b-D-galacto-
hept-2-ulopyranoside)onamide) (8)
This compound was prepared from 1 (0.20 g 0.44 mmol)
according to General procedure I, and was puriﬁed by column
chromatography (1:1 EtOAc–hexane) to give 8 (0.07 g, 31%) as a
white crystalline product, and in the second fraction it gave com-
pound 15 (9%). Mp 163–164 C; [a]D +16 (c 1.03, CHCl3); 1H NMR
(CDCl3, 360 MHz): d (ppm) 7.42–7.33 (m, 5H, ArH), 6.63 (s, 1H,
NH), 5.93 (dd, 1H, J2,3 10.3 Hz, J3,4 3.1 Hz, H-3), 5.68 (d, 1H, J2,3
10.3 Hz, H-2), 5.58–5.54 (m, 2H, H-4, NH), 4.93 (pseudo t, 1H, J5,6
6.8 Hz, J5,60 6.6 Hz, H-5) 4.90, 4.74 (2  d, 2H, J 10.5 Hz, CH2),
4.18–4.12 (m, 2H, H-6, H-60), 2.17, 2.08, 2.03, 1.98 (4  s, 12H,
OCOCH3), 13C NMR (CDCl3, 90 MHz): d (ppm) 170.3 (CONH2,
3JH-2,CO = 6.1 Hz), 169.9, 169.8 (2), 169.7 (CO), 136.7, 128.5,
128.4, 128.0 (ArC), 97.5 (C-1), 71.2, 69.9, 67.3, 65.7 (C-2 to C-5),
64.7 (CH2),61.3 (C-6), 20.7, 20.5, 20.5 (3) (COCH3). Anal. Calcd for
C22H27NO11 (481.46): C, 54.88; H, 5.65; N, 2.91. Found: C, 54.09;
H, 5.62; N, 2.92.
1.12. C-[2,3,4,6-Tetra-O-acetyl-1-(2-nitrophenoxy)-a-D-galacto-
pyranosyl]formamide ((2-nitrophenyl 3,4,5,7-tetra-O-acetyl-b-
D-galacto-hept-2-ulopyranoside)onamide) (9)
To a solution of 1 (0.20 g, 0.44 mmol) in dry CH2Cl2 (2 mL) con-
taining molecular sieves (3 Å), sodium 2-nitrophenolate (0.35 g,
2.20 mmol) was added. The reaction mixture was stirred at rt until
TLC (1:1 EtOAc–hexane) showed complete transformation of the
starting sugar (36 d). Then the mixture was ﬁltered on a Celite
pad, and the solvent was removed. The oily residue was puriﬁed
by column chromatography (1:1 EtOAc–hexane) to give 9 (0.04 g,
24%) as a yellow oil, and in the second fraction it gave compound
15 (0.04 g, 25%). Characterisation of 9: Rf = 0.72 (1:3 EtOAc–hex-
ane); [a]D +52 (c 0.49, CHCl3); 1H NMR (CDCl3, 360 MHz): d
(ppm) 7.97–7.85 (m, 2H, ArH), 7.56 (m, 1H, ArH) 7.28 (s, 1H,
NH), 7.26–7.23 (m, 1H, ArH), 6.23 (s, 1H, NH), 5.79 (dd, 1H, J2,3
10.2 Hz, J3,4 3.1 Hz, H-3), 5.62 (d, 1H, J2,3 10.2 Hz, H-2), 5.54 (dd,
1H, J3,4 3.1 Hz, J4,5 1.1 Hz, H-4), 5.19 (pseudo t, 1H, J5,6 6.1 Hz, J5,60
6.1 Hz, H-5), 4.11–4.06 (m, 2H, H-6, H-60), 2.09, 2.03, 2.01, 1.89
(4  s, 12H, OCOCH3); 13C NMR (CDCl3, 90 MHz): d (ppm): 170.3,
169.5, 169.3, 168.6 (2) (CO), 146.1, 134.0, 126.1, 124.3, 121.5
(ArC), 100.7 (C-1), 72.6, 69.9, 67.3, 65.3 (C-2 to C-5), 61.4 (C-6),
20.5, 20.4, 20.3 (2) (COCH3). Anal. Calcd for C21H24N2O13
(512.43): C, 49.22; H, 4.72; N, 5.47. Found: C, 50.05; H, 4.53; N,
5.29.
1.13. C-[2,3,4,6-Tetra-O-acetyl-1-(4-nitrophenoxy)-a-D-galacto-
pyranosyl]formamide ((4-nitrophenyl 3,4,5,7-tetra-O-acetyl-b-
D-galacto-hept-2-ulopyranoside)onamide) (10)
To a solution of 1 (1.0 g, 2.20 mmol) in dry CH3CN (10 mL) con-
taining molecular sieves (3 Å), sodium 4-nitrophenolate (1.77 g,
11 mmol) was added. The reaction mixture was stirred at rt until
TLC (1:1 EtOAc–hexane) showed the complete transformation of9), doi:10.1016/j.carres.2009.02.011
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the starting sugar (1 d). Then the mixture was ﬁltered on a Celite
pad and the solvent was removed. The oily residue was puriﬁed
by column chromatography (1:1 EtOAc–hexane) to give 10
(0.93 g, 82%) as white crystals from EtOH. Mp: 233–235 C; [a]D
+27 (c 1.10, CHCl3); 1H NMR (CDCl3, 360 MHz): d (ppm) 8.13 (d,
2H, J 9.2 Hz, ArH), 7.37 (d, 2H, J 9.2 Hz, ArH), 6.87 (s, 1H, NH),
6.67 (s, 1H, NH), 5.77 (dd, 1H, J2,3 9.8 Hz, J3,4 2.6 Hz, H-3), 5.54 (d,
1H, J2,3 9.8 Hz, H-2), 5.50 (dd, 1H, J3,4 2.6 Hz, J4,5 1.3 Hz, H-4),
5.00 (pseudo t, 1H, J5,6 6.5 Hz, J5,60 6.5 Hz, H-5), 4.13 (m, 2H, H-6,
H-60), 2.11, 1.99 (2), 1.96 (3  s, 12H, OCOCH3), 13C NMR (CDCl3,
90 MHz): d (ppm) 170.1 (CONH2, 3JH-2,CO = 5.8 Hz), 169.5, 169.4,
168.8 168.3 (CO), 157.2, 143.9, 124.8, 120.9, (ArC), 99.8 (C-1),
72.4, 69.8, 67.0, 66.1 (C-2 to C-5), 61.2 (C-6), 20.4, 20.3 (3) (COCH3).
Anal. Calcd for C21H24N2O13 (512.43): C, 49.22; H, 4.72; N, 5.47.
Found: C, 49.05; H, 4.66; N, 5.32.
1.14. C-[1-(4-nitrophenoxy)-a-D-galactopyranosyl]formamide
((4-nitrophenyl b-D-galacto-hept-2-ulopyranoside)onamide) (11)
To a solution of 10 (0.20 g, 0.39 mmol) in dryMeOH (5 mL) some
crystals of KCN (5 mg) were added. The reaction mixture was stir-
red at rt until TLC (7:3 CHCl3–MeOH) showed the complete transfor-
mation of the starting material (1 d). The reaction mixture was
neutralised with a cation exchange resin Amberlyst 15 (H+ form).
After ﬁltration, the solvent was removed to give 11 (0.15 g, 99%) as
a yellowish oil. Rf = 0.65 (7: 3 CHCl3–MeOH); [a]D +3 (c 0.17, H2O);
1H NMR (D2O, 360 MHz): d (ppm) 8.21 (d, 2H, J 8.6 Hz, ArH), 7.45
(d, 2H, J 8.6 Hz, ArH), 4.51 (pseudo t, 1H, J5,6 6.8 Hz, J5,6’ 5.1 Hz, H-
5), 4.15–4.10 (m, 3H, H-2, H-3, H-4), 3.86–3.78 (m, 2H, H-6, H-60);
13C NMR (D2O, 90 MHz): d (ppm) 170.9 (CONH2, 3JH-2,CO = 4.6 Hz),
158.5, 143.5, 125.6 (2), 120.8 (2) (Ar), 101.8 (C-1), 76.9, 70.5, 69.5,
68.2 (C-2 to C-5), 61.4 (C-6). Anal. Calcd for C13H16N2O9 (344.28):
C, 45.35; H, 4.68; N, 8.14. Found: C, 45.33; H, 4.67; N, 8.10.
1.15. C-(2,3,4,6-Tetra-O-benzoyl-1-ethoxy-a-D-glucopyranosyl)-
formamide ((ethyl 3,4,5,7-tetra-O-benzoyl-b-D-gluco-hept-2-
ulopyranoside)onamide) (12)
This compoundwas prepared from 2 (0.20 g, 0.28 mmol) accord-
ing to General procedure I, and was puriﬁed by column chromatog-
raphy (1:1 EtOAc–hexane) to give 12 (0.16 g, 87%) as a white
crystalline product, and in the second fraction it gave compound
16 (0.02 g, 10%). Characterisation of 12: mp 88–91 C; [a]D +65 (c
1.08, CHCl3); 1H NMR (CDCl3, 360 MHz): d (ppm) 8.01–7.24 (m,
20H, ArH), 6.82 (s, 1H, NH), 6.62 (t, 1H, J 8.8 Hz, J 8.8 Hz, H-3 or H-
4), 6.18 (s, 1H, NH), 5.88–5.80 (m, 2H, H-2, H-3 or H-4), 5.09 (ddd,
1H, J4,5 8.8 Hz, J5,6 6.7 Hz, J5,60 3.2 Hz, H-5), 4.73 (dd, 1H, J6,60
12.1 Hz, J5,6 6.7 Hz, H-6), 4.41 (dd, 1H, J6,60 12.1 Hz, J5,60 3.2 Hz, H-
60), 3.89 (q, 2H, J 6.8 Hz, CH2), 1.18 (t, 3H, J 6.8 Hz, CH3); 13C NMR
(CDCl3, 90 MHz): d (ppm): 169.8 (CONH2, 3JH-2,CO = 4.1 Hz), 166.0,
165.3, 164.9 (2) (CO), 133.4–127.5 (ArC), 97.5 (C-1), 72.1, 72.0,
69.2, 68.8 (C-2 to C-5), 62.5 (C-6), 58.7 (CH2), 15.2 (CH3). Anal. Calcd
for C37H33NO11 (667.68): C, 66.56; H, 4.98; N, 2.10. Found: C, 65.75;
H, 4.87; N, 2.22.
1.16. C-(1-Ethoxy-a-D-glucopyranosyl)formamide ((ethyl b-D-
gluco-hept-2-ulopyranoside)onamide) (13)
This compound was prepared from 12 (0.06 g, 0.13 mmol)
according to General procedure IV, and was puriﬁed by column
chromatography (7:2:1 CHCl3–MeOH–EtOAc) to give 13 (0.02 g,
98%) as a colourless oil. Rf = 0.25 (7:2:1 CHCl3–MeOH–EtOAc);
[a]D +18 (c 0.37, H2O); 1H NMR (D2O, 200 MHz): d (ppm) 3.90–
3.54 (m, 8H, H-2, H-3, H-4, H-5, H-6, H-60, CH2), 1.22 (pseudo t,
3H, J 7.0 Hz, J 6.8 Hz, CH3); 13C NMR (D2O, 50 MHz): d (ppm)
172.6 (CONH2), 99.7 (C-1), 76.4, 75.0, 73.1, 69.5 (C-2 to C-5), 61.4Please cite this article in press as: Nagy, V. et al., Carbohydr. Res. (200E
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(C-6), 59.7 (CH2), 15.0 (CH3). Anal. Calcd for C9H17NO7 (251.24):
C, 43.03; H, 6.82; N, 5.58. Found: C, 43.12; H, 6.75; N, 5.47.
1.17. C-(2,3,4,6-Tetra-O-benzoyl-1-n-buthoxy-a-D-glucopyr-
anosyl)formamide ((n-buthyl 3,4,5,7-tetra-O-benzoyl-b-D-gluco-
hept-2-ulopyranoside)onamide) (14)
This compound was prepared from 2 (0.50 g, 0.71 mmol) accord-
ing toGeneral procedure I, andwas puriﬁed by column chromatogra-
phy (1:2 EtOAc–hexane) to give14 (0.27 g, 56%) as awhite crystalline
product, and in the second fraction it gave compound16 (0.14 g, 31%).
Characterisation of 14: mp 171–173 C; [a]D +64 (c 1.10, CHCl3); 1H
NMR (CDCl3, 360 MHz): d (ppm) 8.10–7.24 (m, 20H, ArH), 6.79 (s,
1H, NH), 6.63 (t, 1H, J 9.2 Hz, J 9.2 Hz, H-3 or H-4), 6.39 (s, 1H, NH),
5.88–5.82 (m, 2H, H-2, H-3 or H-4), 5.09 (ddd, 1H, J4,5 9.2 Hz, J5,6 3.5,
J5,60 3.0 Hz, H-5), 4.75 (dd, 1H, J6,60 12.1 Hz, J5,6 3.5 Hz, H-6), 4.40 (dd,
1H, J6,60 12.1 Hz, J5,60 3.0 Hz, H-60), 3.85–3.80 (m, 2H, CH2), 1.57–1.50
(m, 2H, CH2), 1.32–1.22 (m, 2H, CH2), 0.83 (t, 3H, J 7.1 Hz, J 6.8 Hz,
CH3). 13C NMR (CDCl3, 90 MHz): d (ppm) 169.9 (CONH2, 3JH-
2,CO =4.7 Hz), 165.3 (2), 164.9 (2) (CO), 133.4–128.1 (ArC), 97.5 (C-
1), 72.2, 72.1, 69.3, 68.9 (C-2 to C-5), 62.6 (C-6), 62.5, 31.6, 19.0
(CH2), 13.6 (CH3); Anal. Calcd for C39H37NO11 (695.74): C, 67.33; H,
5.36; N, 2.01. Found: C, 66.95; H, 5.47; N, 2.32.
1.18. C-(2,3,4,6-Tetra-O-acetyl-1-deoxy-1-phenylamino-a-D-
galactopyranosyl)formamide ((N-phenyl 3,4,5,7-tetra-O-
acetyl-b-D-galacto-hept-2-ulopyranosylamine)onamide) (17)
This compoundwas prepared from 1 (0.20 g, 0.44 mmol) accord-
ing to General procedure II. The oily residue was crystallised from
Et2O to give 17 (0.16 g, 75%) as a white crystalline product. Mp:
200–201 C, [a]D 30 (c 1.02, CHCl3); 1H NMR (CDCl3, 360 MHz): d
(ppm) 7.25–7.10 (m, 2H, ArH), 6.88–6.75 (m, H, ArH), 6.47 (s, 1H,
NH), 6.02 (s, 1H, NH), 5.56 (dd, 1H, J3,4 2.9 Hz, H-3), 5.52 (dd, 1H,
J4,5 0.9 Hz, H-4), 5.42 (pseudo t, 1H, J5,6 7.2 Hz, H-5), 5.38 (d,1H, J2,3
9.8 Hz, H-2), 5.05 (s, 1H, NH), 4.08 (dd, 1H, J6,60 11.1 Hz, Hz, H-6),
4.02 (dd, 1H, J5,60 6.8 Hz, H-60), 2.11 (2), 1.99, 1.96 (3  s, 12H,
OCOCH3); 13C NMR (CDCl3, 90 MHz) d (ppm) 171.3, 170.9, 170.3,
170.1, 169.5 (CO), 141.8, 128.9 (2), 120.7, 117.2 (2) (ArC), 86.82 (C-
1), 71.4, 70.2, 68.7, 67.8 (C-2 to C-5), 61.9 (C-6), 20.8, 20.5 (3)
(COCH3). Anal. Calcd for C21H26N2O10 (466.45): C, 54.08; H, 5.62; N,
6.01. Found: C, 54.88; H, 5.50; N, 5.84.
1.19. C-(2,3,4,6-Tetra-O-benzoyl-1-deoxy-1-phenylamino-a-D-
glucopyranosyl)formamide ((N-phenyl 3,4,5,7-tetra-O-benzoyl-
b-D-gluco-hept-2-ulopyranosylamine)onamide) (18)
This compoundwas prepared from 2 (0.50 g, 0.71 mmol) accord-
ing to General procedure II and was puriﬁed by column chromatog-
raphy (1:2 EtOAc–hexane) to give 18 (0.26 g, 55%) from EtOH as
yellowish crystals. Mp 96–97 C [a]D +108 (c 1.33, CHCl3); 1H NMR
(CDCl3, 360 MHz): d (ppm) 8.11–6.80 (m, 25H, ArH), 6.56 (s, 1H,
NH), 6.36 (t, 1H, J 9.1 Hz, J 9.1 Hz, H-3 or H-4), 5.90–5.68 (m, 3H, H-
2, H-3 or H-4, NH), 5.27 (s, 1H, NH), 5.11–4.55 (m, 2H, H-5, H-6),
4.45 (dd,1H, J6,60 12,1 Hz, J5,6’ 3.2, Hz, H-60); 13C NMR (CDCl3,
90 MHz): d (ppm) 171.2 (CONH2, 3JH-2-CO = 4.7 Hz), 166.2 (2),
165.5, 165.4 (CO), 142.0, 128.6 (2), 121.0, 117.5 (2) (ArC), 134.1–
128.3 (benzoyl ArC), 87.0 (C-1), 73.7, 72.8, 70.9, 69.7 (C-2 to C-5),
64.0 (C-6). Anal. Calcd for C41H34N2O10 (714.74): C, 68.90; H, 4.72;
N, 3.92. Found: C, 68.65; H, 4.80; N, 3.26.
1.20. C-(1-Deoxy-1-phenylamino-a-D-glucopyranosyl)formamide
((N-Phenyl b-D-gluco-hept-2-ulopyranosylamine)onamide) (19)
This compound was prepared from 18 (0.15 g, 0.21 mmol)
according to General procedure IV, and was puriﬁed by column9), doi:10.1016/j.carres.2009.02.011
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54%) as a yellowish crystalline product. Mp 140–143 C; [a]D
+115 (c 0.212, H2O); 1H NMR (D2O, 360 MHz): d (ppm) 7.24–6.82
(m, 5H, ArH), 3.84–3.77 (m, 3H, H-5, H-6, H-60), 3.61 (d, 1H, J2,3
9.2 Hz, H-2), 3.60–3.51 (m, 2H, H-3, H-4); 13C NMR (D2O,
90 MHz): d (ppm) 175.4 (CONH2, 3JH-2,CO = 4.0 Hz), 144.5, 129.9
(2), 120.1, 115.6 (2) (ArC), 88.7 (C-1), 74.5, 74.4, 73.1, 69.7 (C-2
to C-5), 60.9 (C-6). Anal. Calcd for C13H18N2O6 (298.30): C, 52.35;
H, 6.08; N, 9.39. Found: C, 52.44; H, 6.23; N, 9.16.500
5101.21. C-(2,3,4,6-Tetra-O-benzoyl-1-deoxy-1-phenylsulfanyl-a-D-
glucopyranosyl)formamide ((phenyl 3,4,5,7-tetra-O-benzoyl-2-
thio-b-D-gluco-hept-2-ulopyranoside)onamide) (20)
This compound was prepared from 2 (0.50 g, 0.70 mmol)
according to General procedure III, and was puriﬁed by column
chromatography (1:2 EtOAc–hexane) to give 20 (0.41 g, 79%) as a
white crystalline product. Mp: 89–92 C; [a]D +33 (c 0.25, CHCl3);
1H NMR (CDCl3, 360 MHz): d (ppm) 8.06–7.14 (m, 25H, ArH),
6.59 (s, 1H, NH2), 6.51 (s, 1H, NH2), 6.11, 5.78, (2  pseudo t, 2H,
J 9.2 Hz in each, H-3, H-4), 5.72 (d, 1H, J2,3 9.2 Hz, H-2), 4.81–
4.76 (m, 2H, H-5, H-6), 4.46 (dd, 1H, J = 11.9, 4.0 Hz, H-60); 13C
NMR (CDCl3, 90 MHz) d (ppm): 168.1 (CONH2, 3JH-2,CO = 4.6 Hz),
166.0, 165.4, 164.9, 164.4 (CO), 136.6, 133.2 (2), 129.7 (3) (thio-
phenyl), 133.1–127.2 (ArC benzoyl), 88.8 (C-1), 73.4, 71.9, 71.2,
68.8 (C-2 to C-5), 62.6 (C-6); Anal. Calcd for C41H33NO10S
(731.28): C, 67.30; H, 4.55; N, 1.91. Found: C, 67.35; H, 4.59; N,
1.96.T
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1.22. C-(1-Deoxy-1-phenylsulfanyl-a-D-glucopyranosyl)formamide
((phenyl 2-thio-b-D-gluco-hept-2-ulopyranoside)onamide) (21)
This compound was prepared from 20 (0.20 g, 0.27 mmol)
according to General procedure IV, and was puriﬁed by column
chromatography (7:3 CHCl3–MeOH) to give 21 (0.07 g, 86%) as a
colourless oil. Rf = 0.74 (1:1 CHCl3–MeOH); [a]D +64 (c 0.19,
H2O); 1H NMR (D2O 360 MHz): d (ppm) 7.72–7.46 (m, 5H, ArH),
3.92 (dd, 1H, J6,60 13.2 Hz, J5,60 1.0 Hz, H-6), 3.80 (dd, 1H, J6,60
13.2 Hz, J5,60 4.0 Hz, H-60), 3.64 (t, 1H, J 9.2 Hz, J 9.2 Hz, H-3 or
H-4), 3.60–3.51 (m, 3H, H-2, H-3 or H-4, H-5); 13C NMR (D2O
90 MHz): d (ppm) 172.2 (CONH2, 3JH-2,CO = 5.8 Hz), 137.3 (2),
130.9, 129.7 (2), 128.0 (tiophenyl), 89.1 (C-1), 78.2, 74.8, 74.6,
69.4 (C-2 to C-5), 61.0 (C-6), Anal. Calcd for C13H17NO6S (315.35):
C, 49.52; H, 5.43; N, 4.44. Found: C, 49.57; H, 5.38; N, 4.48.O
540U
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C1.23. C-[2,3,4,6-Tetra-O-benzoyl-1-deoxy-1-(2-pyridylsulfanyl)-a-D-glucopyranosyl]formamide ((2-pyridyl 3,4,5,7-tetra-O-ben-
zoyl-2-thio-b-D-gluco-hept-2-ulopyranoside)onamide) (22)
This compound was prepared from 2 (0.70 g, 0.98 mmol)
according to General procedure III, and was puriﬁed by column
chromatography (1:1 EtOAc–hexane) to give 22 (0.56 g, 73%) as a
yellow crystalline product. Mp: 78–80 C; [a]D +62 (c 0.17, CHCl3);
1H NMR (CDCl3, 360 MHz): d (ppm) 8.33 (d, 1H, J 2.6 Hz, pyridine),
8.06–7.23 (m, 23H, ArH, pyridine), 7.04 (s, 1H, NH2), 6.60 (s, 1H,
NH2), 6.21 (pseudo t, 1H, J 9.2 Hz, J 9.2 Hz, H-3 or H-4), 6.05 (d,
1H, J2,3 9.2 Hz, H-2), 5.89 (pseudo t, 1H, J 10.6 Hz, J 9.2 Hz, H-3 or
H-4), 4.99 (ddd, 1H, J 10.6 Hz, J 4.0 Hz, J 2.6 Hz, H-5), 4.73 (dd, H,
J 11.9 Hz, J 2.6 Hz, H-6), 4.49 (dd, 1H, J6,60 11.9 Hz, J5,6 4.0 Hz,
H-60); 13C NMR (CDCl3, 90 MHz): d (ppm) 168.6 (CONH2,
3JH-2,CO = 5.9 Hz), 165.8, 165.3, 164.9, 164.4 (CO), 152.5, 149.4,
136.8, 133.1, 122.7 (pyridine), 133.4–128.1 (ArC benzoyl), 88.1
(C-1), 73.7, 71.9, 71.6, 68.9 (C-2 to C-5), 62.8 (C-6); Anal. CalcdPlease cite this article in press as: Nagy, V. et al., Carbohydr. Res. (200E
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for C40H32N2O10S (732.77): C, 65.57; H, 4.40; N, 3.82. Found: C,
65.58; H, 4.36; N, 3.86.
1.24. C-[1-Deoxy-1-(2-pyridylsulfanyl)-a-D-glucopyranosyl]-
formamide ((2-pyridyl 2-thio-b-D-gluco-hept-2-ulopyranoside)-
onamide) (23)
This compound was prepared from 22 (0.20 g, 0.27 mmol)
according to General procedure IV, and was puriﬁed by column
chromatography (7:3 CHCl3–MeOH) to give 23 (0.05 g, 62%) as a
colourless oil. Rf = 0.64 (7:3 CHCl3–MeOH); [a]D +53 (c 0.28,
H2O); 1H NMR (D2O, 360 MHz): d (ppm) 8.59–7.55 (m, 4H, pyri-
dine), 3.93 (dd, 1H, J6,60 11.9 Hz, J5,6 1.0 Hz, H-6), 3.84 (dd, 1H, J6,60
11.9 Hz, J5,60 2.6 Hz, H-60), 3.72 (t, 1H, J 9.2 Hz, J 9.2 Hz, H-3 or H-
4), 3.66–3.58 (m, 3H, H-2, H-3 or H-4, H-5); 13C NMR (D2O,
90 MHz): d (ppm) 171.8 (CONH2, 3JH-2,CO = 5.8 Hz), 150.6, 150.4,
139.2, 133.1, 125.5 (pyridine), 89.3 (C-1), 78.2, 74.8 (2), 69.2 (C-2
to C-5), 60.8 (C-6); Anal. Calcd for C12H16NO6S (316.24): C, 45.56;
H, 5.10; N, 8.86. Found: C, 45.59; H, 5.13; N, 8.89.
1.25. C-[2,3,4,6-Tetra-O-benzoyl-1-deoxy-1-(2-benzothiazolyl-
sulfanyl)-a-D-glucopyranosyl]formamide ((2-Benzothiazolyl
3,4,5,7-tetra-O-benzoyl-2-thio-b-D-gluco-hept-2-ulopyrano-
side)onamide) (24)
This compound was prepared from 2 (0.60 g, 0.84 mmol)
according to General procedure III, and was puriﬁed by column
chromatography (1:1 EtOAc–hexane) to give 24 (0.51 g, 76%) as a
yellow crystalline product. Mp: 105–108 C; [a]D 9 (c 0.17,
CHCl3); 1H NMR (CDCl3, 360 MHz): d (ppm) 8.08–7.10 (m, 24H,
ArH, benzothiazole), 7.24 (s, 1H, NH2), 6.37 (s, 1H, NH2), 6.18 (t,
1H, J 9.2 Hz, J 9.2 Hz, H-3 or H-4), 6.07 (d, 1H, J2,3 9.2 Hz, H-2),
5.98 (t, 1H, J 9.2 Hz, J 9.2 Hz, H-3 or H-4), 5.06 (ddd, 1H, J4,5
9.2 Hz, J5,6 4.0 Hz, J5,601.0 Hz, H-5), 4.84 (dd, 1H, J6,60 13.2 Hz, J5,6
4.0 Hz, H-6), 4.57 (dd, 1H, J6,60 13.2 Hz, J5,60 1.0 Hz, H-60); 13C NMR
(CDCl3, 90 MHz): d (ppm) 167.4 (CONH2, 3JH-2,CO = 4.9 Hz),
165.9, 165.3, 164.9, 164.3 (CO), 157.1, 152.2, 137.3, 126.2, 125.2,
123.0, 120.9 (benzothiazole), 133.7–128.2 (ArC benzoyl), 88.7 (C-
1), 74.3, 71.5 (2), 68.6 (C-2 to C-5), 62.8 (C-6); Anal. Calcd for
C42H32N2O10S2 (788.86): C, 63.95; H, 4.09; N, 3.55. Found: C,
63.99; H, 4.11; N, 3.50.1.26. C-[1-Deoxy-1-(2-benzothiazolylsulfanyl)-a-D-glucopyran-
osyl]formamide ((2-benzothiazolyl 2-thio-b-D-gluco-hept-2-
ulopyranoside)onamide) (25)
This compound was prepared from 24 (0.20 g, 0.25 mmol)
according to General procedure IV, and was puriﬁed by column
chromatography (7:3 CHCl3–MeOH) to give 25 (0.04 g, 47%) as a
yellow crystalline product. Mp: 183–185 C; [a]D +95 (c 0.27,
DMSO); 1H NMR (DMSO-d6, 360 MHz): d (ppm) 8.07–7.41 (m,
4H, benzothiazole), 7.78 (s, 1H, NH2), 7.54 (s, 1H, NH2), 6.26 (d,
1H, J 5.3 Hz, OH), 5.32 (d, 1H, J 4.0 Hz, OH), 5.11 (d, 1H, J 5.3 Hz,
OH), 4.56 (pseudo t, 1H, J 5.3 Hz, J 4.0 Hz, OH), 3.78 (dd, 1H, J6,60
11.9 Hz, J5,6 6.6 Hz, H-6), 3.68–3.56 (m, 5H, H-2, H-3, H-4, H-5,
H-60); 13C NMR (DMSO-d6, 90 MHz): d (ppm) 169.6 (CONH2,
3JH-2,CO = 5.9 Hz), 159.9, 151.7, 136.9, 126.1, 125.2, 122.1, 121.4
(benzothiazole), 87.8 (C-1), 79.1, 74.7, 74.5, 69.1 (C-2 to C-5),
60.9 (C-6), Anal. Calcd for C14H16NO6S2 (372.42): C, 45.15; H,
4.33; N, 7.52. Found: C, 45.05; H, 4.35; N, 7.54.
1.27. X-ray data collection and reduction
Crystals of 4were grown from EtOAc by slow evaporation of the
solution. A colourless block crystal (0.67  0.56  0.4 mm) was9), doi:10.1016/j.carres.2009.02.011
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ﬁxed on a glass capillary using epoxy glue. Data were collected at
293(1) K, Bruker-Nonius MACH3 diffractometer, Mo Ka radiation
k = 0.71073 Å, x motion, hmax = 25.4. The structure was solved
using the SIR-92 software23 and was reﬁned on F2 using SHELX-97
program,24 publication material was prepared with the WINGX-
suite.25 Crystal data: formula C17H25NO11, M = 419.38, monoclinic,
space group P21, a = 8.569(2) Å, b = 18.397(6) Å, c = 13.688(8),
b = 94.32(2), V = 2174(2) Å3, Z = 4, qcalcd = 1.281, 4540 measured,
2899 reﬂections were unique with I > 2r(I), decay: 3%, R1 = 0.088
and wR2 = 0.241 for 4074 reﬂections and 503 parameters,
GOF = 1.11. Residual electron density: 0.7/0.31 e/Å3.
Hydrogen atoms were ﬁxed into geometric position except N–H
hydrogens which could be found at the difference electron density
map, but were also ﬁxed into calculated positions in the ﬁnal stage
of the reﬁnement. There is a remaining electron density (0.7 e/Å3)
close to the acetyl carbon atomof C16whichmay indicate some dis-
order of this acetyl group. However, this has no effect on our main
ﬁndings concerning the conﬁguration of the anomeric carbon.
Anisotropic reﬁnement of non-hydrogen atoms was performed ex-
cept atoms of the C16 acetyl group. Orientation of methyl groups
was reﬁned using a riding model. There are two molecules found
in the asymmetric unitwith slightly different bond length and angle
data as indicated in Figure 1, too. The structure is stabilised with
intermolecular hydrogenbondsbetween the amidehydrogenatoms
and theO8 acetylene or O11 amide carbonyl oxygen atoms of a sym-
metry relatedmolecule. Intramolecular hydrogen bond betweenO1
and the amide proton causes nearly planar orientation of O1–C1–
C7–O11–N1. The uniqueness of compound 4 is shown by the fact
that no similar structure could be found in the Cambridge Structural
Database26 (Ver. 5.29, November 2007 with upgrades in 2008) con-
taining an amide group aswell as oxygen connected to the anomeric
carbon atom. Additional crystallographic information is provided in
the deposited CIF: CCDC 714419.
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